Le Lézard
Classified in: Business
Subjects: CCA, FVT

Chemours Announces Dates for Third Quarter 2017 Earnings Release and Webcast Conference Call



WILMINGTON, Del., Oct. 5, 2017 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced it will release third quarter financial results after market close on Thursday, November 2, 2017. The company will conduct its third quarter 2017 webcast conference call on Friday, November 3, 2017 at 8:30 a.m. Eastern Standard Time. The call is open to the public and can be accessed via live webcast and teleconference.

Conference Call:   Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides.

Replay:                   A webcast replay will be available at investors.chemours.com 

About The Chemours Company
The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing.  Our flagship products include prominent brands such as Teflontm, Ti-Puretm, Krytoxtm, Vitontm, Opteontm, Freontm and Nafiontm.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com.

CONTACT

MEDIA
Alvenia Scarborough
Director of Brand Marketing and Corporate Communications
+1.302.773.4507
media@chemours.com 

INVESTORS
Alisha Bellezza
Treasurer and Director of Investor Relations
+1.302.773.2263
investor@chemours.com

SOURCE The Chemours Company


These press releases may also interest you

at 22:21
BEIJING, Oct. 19, 2017 /PRNewswire/ -- China Renaissance is pleased to have been awarded Technology, Media & Telecom M&A Financial Adviser of the Year at the inaugural China M&A Awards held by Mergermarket. "We are especially honored as this award...

at 22:00
SAN DIEGO, Oct. 19, 2017 /PRNewswire/ -- Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), and SenseTime Group Limited today announced plans to collaborate on artificial intelligence (AI) and machine learning (ML) for...

at 21:30
DALLAS, Oct. 19, 2017 /PRNewswire/ -- The anticipated Water Token ICO, that has the Ethereum/blockchain market buzzing, has been downloaded by thousands of potential investors in anticipation of the Oct. 25 launch. Darren McVean, CEO of MVP Asia...

at 21:07
SAO PAULO, Oct. 19, 2017 /PRNewswire/ -- Companhia de Saneamento Básico do Estado de São Paulo ? Sabesp ("Company" or "Sabesp"), pursuant to article 157, paragraph 4 of Law 6,404/76 and CVM Instruction 358/02, hereby informs its shareholders and the...

at 21:00
OCEAN VIEW, Del., Oct. 19, 2017 /PRNewswire-iReach/ -- Automotive Air Intake Manifold Market is poised to be valued USD 51 Billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing vehicle production will...

at 21:00
TOKYO, Oct. 19, 2017 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Universal Cells, Inc. (CEO: Claudia Mitchell, "Universal Cells") today announced that Astellas Institute for Regenerative...




News published on 5 october 2017 at 16:15 and distributed by: